Journey Medical Corp - DERM Net earnings per share for the last four quarters

Journey Medical (DERM) - corporate logo

Journey Medical is developing an aggressive sales system, attracting top managers through high bonuses and KPIs. This price chart, serving as the primary evaluation tool where the EPS TTM is 49.80, links commercial success to the creation of high-efficiency formulations for treating rosacea and acne. The company is relying on organic growth and partner networks, having temporarily stepped away from mergers and acquisitions.

DERM: Journey Medical Corp. Earnings per share for the last twelve months 02/11/2024 - 11/17/2026

Financial and market metric breakdowns for Journey Medical (DERM)

- current quotes and average value forecast:
Initial company analysis:Journey Medical Corp. DERM
Core merchandise of Journey Medical Corp.

Annual net income per share dynamics reflect the efficiency of asset monetization and the pace of business scaling. This metric measures the percentage change in earnings (TTM), allowing for an assessment of the real recovery rate of profitability. By analyzing the current EPS YoY TTM growth rate, an investor can see the impact of patent protection and FDA barriers on the capitalization of Journey Medical (DERM). Stable growth confirms the resilience of the company's market position against new competitors.